A 0 1 0 1 O
minimum 2 9 2 9 O
of 10 12 10 12 O
6 13 14 13 14 B-lower_bound
weeks 15 20 15 20 I-lower_bound
is 21 23 21 23 O
required 24 32 24 32 O
following 33 42 33 42 O
prior 43 48 43 48 B-treatment
large 49 54 49 54 I-treatment
field 55 60 55 60 I-treatment
radiation 61 70 61 70 I-treatment
therapy 71 78 71 78 I-treatment
( 79 80 79 80 O
i.e. 80 84 80 84 O
TBI 85 88 85 88 B-chronic_disease
, 88 89 88 89 O
craniospinal 90 102 90 102 B-treatment
therapy 103 110 103 110 I-treatment
, 110 111 110 111 O
whole 112 117 112 117 O
abdomen 118 125 118 125 O
, 125 126 125 126 O
total 127 132 127 132 O
lung 133 137 133 137 O
, 137 138 137 138 O
> 139 140 139 140 O
50 141 143 141 143 B-lower_bound
% 143 144 143 144 I-lower_bound
marrow 145 151 145 151 B-clinical_variable
space 152 157 152 157 I-clinical_variable
) 157 158 157 158 O

Bone 0 4 159 163 O
marrow 5 11 164 170 O
with 12 16 171 175 O
tumor 17 22 176 181 B-cancer
cells 23 28 182 187 O
seen 29 33 188 192 O
on 34 36 193 195 O
routine 37 44 196 203 O
morphology 45 55 204 214 O
( 56 57 215 216 O
not 57 60 216 219 O
by 61 63 220 222 O
NSE 64 67 223 226 O
staining 68 76 227 235 O
only 77 81 236 240 O
) 81 82 240 241 O
of 83 85 242 244 O
bilateral 86 95 245 254 B-treatment
aspirate 96 104 255 263 I-treatment
and/or 105 111 264 270 O
biopsy 112 118 271 277 B-treatment
on 119 121 278 280 O
one 122 125 281 284 O
bone 126 130 285 289 O
marrow 131 137 290 296 O
sample 138 144 297 303 O

CNS 0 3 304 307 O
lesions 4 11 308 315 O
: 11 12 315 316 O
A 13 14 317 318 O
) 14 15 318 319 O
Patients 16 24 320 328 O
with 25 29 329 333 O
CNS 30 33 334 337 B-cancer
parenchymal 34 45 338 349 I-cancer
or 46 48 350 352 O
meningeal 49 58 353 362 B-cancer
- 58 59 362 363 I-cancer
based 59 64 363 368 I-cancer
lesions 65 72 369 376 I-cancer
that 73 77 377 381 O
are 78 81 382 385 O
present 82 89 386 393 O
at 90 92 394 396 O
study 93 98 397 402 O
entry 99 104 403 408 O
are 105 108 409 412 O
NOT 109 112 413 416 O
eligible 113 121 417 425 O
due 122 125 426 429 O
to 126 128 430 432 O
concerns 129 137 433 441 O
regarding 138 147 442 451 O
toxicity 148 156 452 460 O
attribution 157 168 461 472 O

Diseases 0 8 473 481 O
refractory 9 19 482 492 O
/ 19 20 492 493 O
relapsed 20 28 493 501 O
after 29 34 502 507 O
one 35 38 508 511 B-lower_bound
or 39 41 512 514 O
more 42 46 515 519 O
systemic 47 55 520 528 B-treatment
cytotoxic 56 65 529 538 I-treatment
therapies 66 75 539 548 I-treatment

For 0 3 549 552 O
patients 4 12 553 561 O
with 13 17 562 566 O
persistent 18 28 567 577 O
disease 29 36 578 585 O
, 36 37 585 586 O
a 38 39 587 588 O
biopsy 40 46 589 595 B-treatment
of 47 49 596 598 I-treatment
bone 50 54 599 603 I-treatment
marrow 55 61 604 610 I-treatment
, 61 62 610 611 O
or 63 65 612 614 O
bone 66 70 615 619 O
, 70 71 619 620 O
or 72 74 621 623 O
a 75 76 624 625 O
soft 77 81 626 630 B-treatment
tissue 82 88 631 637 I-treatment
site 89 93 638 642 I-treatment
, 93 94 642 643 O
must 95 99 644 648 O
have 100 104 649 653 O
demonstrated 105 117 654 666 O
viable 118 124 667 673 B-cancer
tumor 125 130 674 679 I-cancer

Growth 0 6 680 686 O
factor(s 7 15 687 695 O
): 15 17 695 697 O
Must 18 22 698 702 O
not 23 26 703 706 O
have 27 31 707 711 O
received 32 40 712 720 O
any 41 44 721 724 O
hematopoetic 45 57 725 737 B-treatment
growth 58 64 738 744 I-treatment
factors 65 72 745 752 I-treatment
within 73 79 753 759 O
7 80 81 760 761 B-upper_bound
days 82 86 762 766 I-upper_bound
of 87 89 767 769 O
study 90 95 770 775 O
entry 96 101 776 781 O

Known 0 5 782 787 O
history 6 13 788 795 O
of 14 16 796 798 O
, 16 17 798 799 O
or 18 20 800 802 O
positive 21 29 803 811 O
test 30 34 812 816 O
result 35 41 817 823 O
for 42 45 824 827 O
human 46 51 828 833 B-chronic_disease
immunodeficiency 52 68 834 850 I-chronic_disease
virus 69 74 851 856 I-chronic_disease
( 75 76 857 858 I-chronic_disease
HIV 76 79 858 861 I-chronic_disease
) 79 80 861 862 I-chronic_disease
infection 81 90 863 872 O

Measurable 0 10 873 883 O
is 11 13 884 886 O
defined 14 21 887 894 O
as 22 24 895 897 O
at 25 27 898 900 O
least 28 33 901 906 O
one 34 37 907 910 B-lower_bound
lesion 38 44 911 917 O
20 45 47 918 920 O
mm 48 50 921 923 O
in 51 53 924 926 O
at 54 56 927 929 O
least 57 62 930 935 O
one 63 66 936 939 O
dimension 67 76 940 949 O

Measurable 0 10 950 960 O
tumor 11 16 961 966 B-cancer
on 17 19 967 969 O
MRI 20 23 970 973 B-treatment
or 24 26 974 976 O
CT 27 29 977 979 B-treatment
scan 30 34 980 984 I-treatment

Organ 0 5 985 990 B-treatment
Transplant 6 16 991 1001 I-treatment
: 16 17 1001 1002 O
Patients 18 26 1003 1011 O
may 27 30 1012 1015 O
NOT 31 34 1016 1019 O
be 35 37 1020 1022 O
the 38 41 1023 1026 O
recipients 42 52 1027 1037 O
of 53 55 1038 1040 O
an 56 58 1041 1043 O
organ 59 64 1044 1049 B-treatment
transplant 65 75 1050 1060 I-treatment

Participation 0 13 1061 1074 O
in 14 16 1075 1077 O
any 17 20 1078 1081 O
other 21 26 1082 1087 O
investigational 27 42 1088 1103 B-treatment
treatment 43 52 1104 1113 I-treatment
within 53 59 1114 1120 O
the 60 63 1121 1124 O
6 64 65 1125 1126 B-upper_bound
weeks 66 71 1127 1132 I-upper_bound
prior 72 77 1133 1138 I-upper_bound
to 78 80 1139 1141 O
enrollment 81 91 1142 1152 O
or 92 94 1153 1155 O
concurrent 95 105 1156 1166 O
with 106 110 1167 1171 O
this 111 115 1172 1176 O
study 116 121 1177 1182 O

Patients 0 8 1183 1191 O
concurrently 9 21 1192 1204 O
taking 22 28 1205 1211 O
the 29 32 1212 1215 O
following 33 42 1216 1225 O
drugs 43 48 1226 1231 O
are 49 52 1232 1235 O
excluded 53 61 1236 1244 O
: 61 62 1244 1245 O
antioxidants 63 75 1246 1258 B-treatment
, 75 76 1258 1259 O
herbal 77 83 1260 1266 B-treatment
or 84 86 1267 1269 O
other 87 92 1270 1275 O
alternative 93 104 1276 1287 B-treatment
therapy 105 112 1288 1295 I-treatment
medications 113 124 1296 1307 I-treatment
, 124 125 1307 1308 O
vitamin 126 133 1309 1316 B-treatment
supplements 134 145 1317 1328 I-treatment
( 146 147 1329 1330 O
especially 147 157 1330 1340 O
vitamins 158 166 1341 1349 O
A 167 168 1350 1351 O
, 168 169 1351 1352 O
C 170 171 1353 1354 O
, 171 172 1354 1355 O
and 173 176 1356 1359 O
E 177 178 1360 1361 O
) 178 179 1361 1362 O
other 180 185 1363 1368 O
than 186 190 1369 1373 O
at 191 193 1374 1376 O
standard 194 202 1377 1385 O
multivitamin 203 215 1386 1398 O
doses 216 221 1399 1404 O
, 221 222 1404 1405 O
cyclosporine 223 235 1406 1418 B-treatment
A 236 237 1419 1420 I-treatment
or 238 240 1421 1423 O
analogue 241 249 1424 1432 B-treatment
; 249 250 1432 1433 O
verapamil 251 260 1434 1443 B-treatment
; 260 261 1443 1444 O
tamoxifen 262 271 1445 1454 B-treatment
or 272 274 1455 1457 O
analogue 275 283 1458 1466 O
, 283 284 1466 1467 O
ketoconazole 285 297 1468 1480 B-treatment
, 297 298 1480 1481 O
chlorpromazine 299 313 1482 1496 B-treatment
; 313 314 1496 1497 O
RU486 315 320 1498 1503 B-treatment
; 320 321 1503 1504 O
indomethacin 322 334 1505 1517 B-treatment
; 334 335 1517 1518 O
or 336 338 1519 1521 O
sulfinpyrazone 339 353 1522 1536 B-treatment
, 353 354 1536 1537 O
tetracycline 355 367 1538 1550 B-treatment
, 367 368 1550 1551 O
nalidixic 369 378 1552 1561 B-treatment
acid 379 383 1562 1566 I-treatment
, 383 384 1566 1567 O
nitrofurantoin 385 399 1568 1582 B-treatment
, 399 400 1582 1583 O
phenytoin 401 410 1584 1593 B-treatment
, 410 411 1593 1594 O
sulfonamides 412 424 1595 1607 B-treatment
, 424 425 1607 1608 O
lithium 426 433 1609 1616 B-treatment
, 433 434 1616 1617 O
and 435 438 1618 1621 O
amiodarone 439 449 1622 1632 B-treatment

Patients 0 8 1633 1641 O
must 9 13 1642 1646 O
have 14 18 1647 1651 O
otherwise 19 28 1652 1661 O
recovered 29 38 1662 1671 O
from 39 43 1672 1676 O
toxicities 44 54 1677 1687 B-chronic_disease
of 55 57 1688 1690 O
prior 58 63 1691 1696 B-treatment
therapy 64 71 1697 1704 I-treatment

Patients 0 8 1705 1713 O
must 9 13 1714 1718 O
not 14 17 1719 1722 O
have 18 22 1723 1727 O
received 23 31 1728 1736 O
small 32 37 1737 1742 O
field 38 43 1743 1748 O
( 44 45 1749 1750 O
focal 45 50 1750 1755 O
) 50 51 1755 1756 O
radiation 52 61 1757 1766 B-treatment
for 62 65 1767 1770 O
a 66 67 1771 1772 O
minimum 68 75 1773 1780 O
of 76 78 1781 1783 O
2 79 80 1784 1785 B-upper_bound
weeks 81 86 1786 1791 I-upper_bound
prior 87 92 1792 1797 I-upper_bound
to 93 95 1798 1800 O
study 96 101 1801 1806 O
entry 102 107 1807 1812 O

Patients 0 8 1813 1821 O
who 9 12 1822 1825 O
have 13 17 1826 1830 O
had 18 21 1831 1834 O
major 22 27 1835 1840 B-treatment
non 28 31 1841 1844 I-treatment
- 31 32 1844 1845 I-treatment
biopsy 32 38 1845 1851 I-treatment
surgery 39 46 1852 1859 I-treatment
in 47 49 1860 1862 O
the 50 53 1863 1866 O
last 54 58 1867 1871 B-upper_bound
20 59 61 1872 1874 I-upper_bound
days 62 66 1875 1879 I-upper_bound

Patients 0 8 1880 1888 O
who 9 12 1889 1892 O
have 13 17 1893 1897 O
received 18 26 1898 1906 O
chemotherapy 27 39 1907 1919 B-treatment
within 40 46 1920 1926 O
3 47 48 1927 1928 B-upper_bound
weeks 49 54 1929 1934 I-upper_bound
of 55 57 1935 1937 O
first 58 63 1938 1943 O
fenretinide 64 75 1944 1955 B-treatment
treatment 76 85 1956 1965 I-treatment

Patients 0 8 1966 1974 O
who 9 12 1975 1978 O
have 13 17 1979 1983 O
uncontrolled 18 30 1984 1996 O
systemic 31 39 1997 2005 B-chronic_disease
infections 40 50 2006 2016 I-chronic_disease

Patients 0 8 2017 2025 O
with 9 13 2026 2030 O
an 14 16 2031 2033 O
ECOG 17 21 2034 2038 B-clinical_variable
performance 22 33 2039 2050 I-clinical_variable
status 34 40 2051 2057 I-clinical_variable
of 41 43 2058 2060 O
0 44 45 2061 2062 B-lower_bound
, 45 46 2062 2063 O
1 47 48 2064 2065 O
, 48 49 2065 2066 O
or 50 52 2067 2069 O
2 53 54 2070 2071 B-upper_bound
, 54 55 2071 2072 O
and 56 59 2073 2076 O
estimated 60 69 2077 2086 O
survival 70 78 2087 2095 O
of 79 81 2096 2098 O
> 82 83 2099 2100 O
12 84 86 2101 2103 B-lower_bound
weeks 87 92 2104 2109 I-lower_bound

Patients 0 8 2110 2118 O
with 9 13 2119 2123 O
an 14 16 2124 2126 O
identified 17 27 2127 2137 O
familial 28 36 2138 2146 B-chronic_disease
hyperlipidemia 37 51 2147 2161 I-chronic_disease
disorder 52 60 2162 2170 I-chronic_disease

Patients 0 8 2171 2179 O
with 9 13 2180 2184 O
any 14 17 2185 2188 O
active 18 24 2189 2195 O
hepatitis 25 34 2196 2205 B-chronic_disease
infections 35 45 2206 2216 I-chronic_disease

Patients 0 8 2217 2225 O
with 9 13 2226 2230 O
documented 14 24 2231 2241 O
allergy 25 32 2242 2249 O
to 33 35 2250 2252 O
egg 36 39 2253 2256 B-allergy_name
products 40 48 2257 2265 I-allergy_name

Patients 0 8 2266 2274 O
with 9 13 2275 2279 O
documented 14 24 2280 2290 O
allergy 25 32 2291 2298 O
to 33 35 2299 2301 O
soy 36 39 2302 2305 B-allergy_name
products 40 48 2306 2314 I-allergy_name

Patients 0 8 2315 2323 O
with 9 13 2324 2328 O
fasting 14 21 2329 2336 B-clinical_variable
serum 22 27 2337 2342 I-clinical_variable
triglycerides 28 41 2343 2356 I-clinical_variable
> 42 43 2357 2358 O
300 44 47 2359 2362 B-lower_bound
and/or 48 54 2363 2369 O
with 55 59 2370 2374 O
hypertriglyceridemia 60 80 2375 2395 B-chronic_disease
requiring 81 90 2396 2405 O
medication 91 101 2406 2416 B-treatment

Patients 0 8 2417 2425 O
with 9 13 2426 2430 O
poorly 14 20 2431 2437 O
controlled 21 31 2438 2448 O
diabetes 32 40 2449 2457 B-chronic_disease
mellitus 41 49 2458 2466 I-chronic_disease
with 50 54 2467 2471 O
fasting 55 62 2472 2479 B-clinical_variable
serum 63 68 2480 2485 I-clinical_variable
glucose 69 76 2486 2493 I-clinical_variable
concentration 77 90 2494 2507 I-clinical_variable
over 91 95 2508 2512 O
200 96 99 2513 2516 B-lower_bound
mg 100 102 2517 2519 I-lower_bound
/ 102 103 2519 2520 I-lower_bound
dl 103 105 2520 2522 I-lower_bound
or 106 108 2523 2525 O
a 109 110 2526 2527 O
hemoglobin 111 121 2528 2538 B-clinical_variable
A1C 122 125 2539 2542 I-clinical_variable
over 126 130 2543 2547 O
7.5 131 134 2548 2551 B-lower_bound
% 134 135 2551 2552 I-lower_bound

Patients 0 8 2553 2561 O
with 9 13 2562 2566 O
previously 14 24 2567 2577 O
treated 25 32 2578 2585 O
leptomeningeal 33 47 2586 2600 B-cancer
disease 48 55 2601 2608 I-cancer
or 56 58 2609 2611 O
brain 59 64 2612 2617 B-cancer
metastases 65 75 2618 2628 I-cancer
without 76 83 2629 2636 O
evidence 84 92 2637 2645 O
of 93 95 2646 2648 O
remaining 96 105 2649 2658 O
tumor 106 111 2659 2664 B-cancer
by 112 114 2665 2667 O
PET 115 118 2668 2671 B-treatment
, 118 119 2671 2672 O
MRI 120 123 2673 2676 B-treatment
scan 124 128 2677 2681 I-treatment
, 128 129 2681 2682 O
or 130 132 2683 2685 O
spinal 133 139 2686 2692 O
fluid 140 145 2693 2698 O

Patients 0 8 2699 2707 O
with 9 13 2708 2712 O
uncontrolled 14 26 2713 2725 O
hypertension 27 39 2726 2738 B-chronic_disease

Who 0 3 2739 2742 O
have 4 8 2743 2747 O
active 9 15 2748 2754 O
CNS 16 19 2755 2758 B-chronic_disease
disease 20 27 2759 2766 I-chronic_disease
or 28 30 2767 2769 O
a 31 32 2770 2771 O
history 33 40 2772 2779 O
of 41 43 2780 2782 O
cranial 44 51 2783 2790 B-treatment
irradiation 52 63 2791 2802 I-treatment
are 64 67 2803 2806 O
excluded 68 76 2807 2815 O
due 77 80 2816 2819 O
to 81 83 2820 2822 O
concerns 84 92 2823 2831 O
regarding 93 102 2832 2841 O
toxicity 103 111 2842 2850 O
attribution 112 123 2851 2862 O

Women 0 5 2863 2868 B-gender
who 6 9 2869 2872 O
are 10 13 2873 2876 B-pregnancy
pregnant 14 22 2877 2885 I-pregnancy

coagulation 0 11 2886 2897 B-chronic_disease
disorders 12 21 2898 2907 I-chronic_disease

for 0 3 2908 2911 O
spiral 4 10 2912 2918 B-treatment
CT 11 13 2919 2921 I-treatment
, 13 14 2921 2922 O
measurable 15 25 2923 2933 O
is 26 28 2934 2936 O
defined 29 36 2937 2944 O
as 37 39 2945 2947 O
10 40 42 2948 2950 O
mm 43 45 2951 2953 O
in 46 48 2954 2956 O
at 49 51 2957 2959 O
least 52 57 2960 2965 O
one 58 61 2966 2969 B-lower_bound
dimension 62 71 2970 2979 O

other 0 5 2980 2985 O
major 6 11 2986 2991 B-chronic_disease
medical 12 19 2992 2999 I-chronic_disease
illnesses 20 29 3000 3009 I-chronic_disease
of 30 32 3010 3012 I-chronic_disease
the 33 36 3013 3016 I-chronic_disease
cardiovascular 37 51 3017 3031 I-chronic_disease
or 52 54 3032 3034 O
respiratory 55 66 3035 3046 B-chronic_disease
systems 67 74 3047 3054 I-chronic_disease

patient 0 7 3055 3062 O
who 8 11 3063 3066 O
tested 12 18 3067 3073 O
positive 19 27 3074 3082 O
subsequent 28 38 3083 3093 O
to 39 41 3094 3096 O
their 42 47 3097 3102 O
last 48 52 3103 3107 O
treatment 53 62 3108 3117 B-treatment
regimen 63 70 3118 3125 O

patients 0 8 3126 3134 O
currently 9 18 3135 3144 O
taking 19 25 3145 3151 O
steroids 26 34 3152 3160 B-treatment
as 35 37 3161 3163 O
prophylaxis 38 49 3164 3175 O
against 50 57 3176 3183 O
seizures 58 66 3184 3192 B-chronic_disease

patients 0 8 3193 3201 O
must 9 13 3202 3206 O
have 14 18 3207 3211 O
fully 19 24 3212 3217 O
recovered 25 34 3218 3227 O
from 35 39 3228 3232 O
the 40 43 3233 3236 O
acute 44 49 3237 3242 O
toxic 50 55 3243 3248 O
effects 56 63 3249 3256 O
of 64 66 3257 3259 O
all 67 70 3260 3263 O
prior 71 76 3264 3269 B-treatment
chemotherapy 77 89 3270 3282 I-treatment
, 89 90 3282 3283 O
immunotherapy 91 104 3284 3297 B-treatment
, 104 105 3297 3298 O
or 106 108 3299 3301 O
radiotherapy 109 121 3302 3314 B-treatment
prior 122 127 3315 3320 I-treatment
to 128 130 3321 3323 O
entering 131 139 3324 3332 O
this 140 144 3333 3337 O
study 145 150 3338 3343 O

patients 0 8 3344 3352 O
who 9 12 3353 3356 O
had 13 16 3357 3360 O
a 17 18 3361 3362 O
negative 19 27 3363 3371 O
marrow 28 34 3372 3378 O
within 35 41 3379 3385 O
three 42 47 3386 3391 B-upper_bound
months 48 54 3392 3398 I-upper_bound
of 55 57 3399 3401 O
study 58 63 3402 3407 O
entry 64 69 3408 3413 O

patients 0 8 3414 3422 O
with 9 13 3423 3427 O
hypercholesterolemia 14 34 3428 3448 B-chronic_disease
with 35 39 3449 3453 O
or 40 42 3454 3456 O
without 43 50 3457 3464 O
medication 51 61 3465 3475 B-treatment

who 0 3 3476 3479 O
have 4 8 3480 3484 O
received 9 17 3485 3493 O
investigational 18 33 3494 3509 B-treatment
drugs 34 39 3510 3515 I-treatment
within 40 46 3516 3522 O
6 47 48 3523 3524 B-upper_bound
weeks 49 54 3525 3530 I-upper_bound
of 55 57 3531 3533 O
first 58 63 3534 3539 O
fenretinide 64 75 3540 3551 B-treatment
treatment 76 85 3552 3561 I-treatment

with 0 4 3562 3566 O
histologically 5 19 3567 3581 O
or 20 22 3582 3584 O
cytologically 23 36 3585 3598 O
confirmed 37 46 3599 3608 O
Peripheral 47 57 3609 3619 B-cancer
T 58 59 3620 3621 I-cancer
- 59 60 3621 3622 I-cancer
cell 60 64 3622 3626 I-cancer
lymphoma 65 73 3627 3635 I-cancer
( 74 75 3636 3637 I-cancer
PTCL 75 79 3637 3641 I-cancer
) 79 80 3641 3642 I-cancer

